<DOC>
	<DOC>NCT00436371</DOC>
	<brief_summary>To collect the safety and response of using Amisulpride in acute schizophrenic patients</brief_summary>
	<brief_title>Amisulpride in Schizophrenic Acute Phase Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Patient diagnosed as Diagnostic and Statistical Manual of Mental Disorder, 4th edition, as paranoid, disorganized or undifferentiated type of schizophrenia in acute episode Patients previously treated with amisulpride Patients have comorbidity which may interfere with the treatment or followup Patients currently taking depot antipsychotics (at least 30 days washout period is needed) Patients currently/ or recently (&lt; 3 months) withdrawn from drug or alcohol abuse Pregnant or lactation The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>